Hall Shannon
Director at MLAB; Executive Vice President at BIO
- Sold, on record
- $887k
- Dollars the filings state
- Form 4 sales
- 10
- Latest Dec 8, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale BIOPlan not statedSep 14, 2015 2015
Sold 182 shares at $139.11 ($25k)
Hall Shannon, Executive Vice President
Sold 9.8% of holdings ($258k position)1,675 shares leftFiling
- 2 Form 4 sale BIOUnusualJun 13, 2016 +273 days
Sold 1,572 shares at $145.29 ($228k)
Hall Shannon, Executive Vice President
Sold 82.4% of holdings ($277k position)336 shares left17.1x usual sizeFiling
- 3 Form 4 sale BIOUnusualSep 12, 2016 +91 days
Sold 414 shares at $155.02 ($64k)
Hall Shannon, Executive Vice President
Sold 27.5% of holdings ($234k position)1,093 shares left3x usual sizeFiling
- 4 Form 4 sale BIOPlan not statedSep 13, 2016 +1 day
Sold 92 shares at $158.08 ($15k)
Hall Shannon, Executive Vice President
Sold 6.9% of holdings ($211k position)1,241 shares left0.5x usual sizeFiling
- 5 Form 4 sale BIOPlan not statedNov 7, 2016 +55 days
Sold 84 shares at $165.62 ($14k)
Hall Shannon, Executive Vice President
Sold 5.7% of holdings ($244k position)1,390 shares left0.6x usual sizeFiling
- 6 Form 4 sale BIOUnusualMay 31, 2017 +205 days
Sold 900 shares at $222.65 ($200k)
Hall Shannon, Executive Vice President
Sold 61.6% of holdings ($325k position)560 shares left9.8x usual sizeFiling
- 7 Form 4 sale BIOUnusualSep 13, 2017 +105 days
Sold 1,245 shares at $221.20 ($275k)
Hall Shannon, Executive Vice President
Sold 68.8% of holdings ($400k position)565 shares left4.2x usual sizeFiling
- 8 Form 4 sale MLABPlan not statedDec 8, 2022 +1912 days
Sold 230 shares at $174.98 ($40k)
Hall Shannon, Director
Sold 19.4% of holdings ($208k position)957 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Dec 9, 2022 | MLAB | Director | Form 4 sale | 230 | $40k | 19.4% | Plan not stated | SEC |
| Sep 13, 2017 | Sep 14, 2017 | BIO | Executive Vice President | Form 4 sale | 1,245 | $275k | 68.8% | Unusual | SEC |
| May 31, 2017 | Jun 1, 2017 | BIO | Executive Vice President | Form 4 sale | 900 | $200k | 61.6% | Unusual | SEC |
| Nov 7, 2016 | Nov 8, 2016 | BIO | Executive Vice President | Form 4 sale | 84 | $14k | 5.7% | Plan not stated | SEC |
| Sep 13, 2016 | Sep 14, 2016 | BIO | Executive Vice President | Form 4 sale | 92 | $15k | 6.9% | Plan not stated | SEC |
| Sep 12, 2016 | Sep 13, 2016 | BIO | Executive Vice President | Form 4 sale | 414 | $64k | 27.5% | Unusual | SEC |
| Jun 13, 2016 | Jun 14, 2016 | BIO | Executive Vice President | Form 4 sale | 1,572 | $228k | 82.4% | Unusual | SEC |
| Sep 14, 2015 | Sep 15, 2015 | BIO | Executive Vice President | Form 4 sale | 182 | $25k | 9.8% | Plan not stated | SEC |
| Sep 11, 2015 | Sep 14, 2015 | BIO | Executive Vice President | Form 4 sale | 92 | $13k | 6.3% | Plan not stated | SEC |
| Sep 9, 2015 | Sep 10, 2015 | BIO | Executive Vice President | Form 4 sale | 84 | $12k | 6.4% | Plan not stated | SEC |